Member Info for MickTKipper

OCDO Ocado on a nice early run.......

https://uk.advfn.com/p.php?pid=legacyintra&epic=L^OCDO&type=1&size=3&period=a&freq=1&ind_type1=1&ind1_1=&ind2_1=&olx_1=&scheme=&delay_indices=DELAYED_INDICES

Peston no not me tweeting to him a chap on twitter.

Pestons show is on ITV tonight as well we might get a mention of this tie up deal for
NYCT. ITV 10.45pm. Would be a big plus for the company.

Novacyt's COVID testing kit gets thumbs up from World Health Organisation
08-04-2020 07:10

PARIS, April 8 (Reuters) – Novacyt's
COVID-19 diagnostic test has been deemed as eligible for procurement under the World Health Organisation's (WHO) Emergency Use Listing process, the company said on Wednesday.

The test has been developed by Novacyt’s molecular diagnostics division, Primerdesign, based in Southampton, England.

"The Emergency Use Listing by the WHO importantly provides further validation of our COVID-19 test and gives government agencies around the world further confidence in the effectiveness of our test," Novacyt CEO Graham Mullis said.

(Reporting by Sudip Kar-Gupta; editing by Jason Neely) ((sudip.kargupta@thomsonreuters.com; +33 1 49 49 53 84;)

NCYT...........NOVACYT..............just the start of the news flow........

https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/partnership-with-az--gsk---university-of-cambridge/202004080700051392J/

AND

https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/covid-test-eligible-for-who-emergency-use-listing/202004080700041286J/

Just look at that gap up.

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^NCYT&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Ocado Group Plc OCDO Berenberg Buy 1,316.00 1,389.00 1,635.00 - Reiterates........ SP target 1,635pOcado Group Plc OCDO Berenberg Buy 1,316.00 1,389.00 1,635.00 - Reiterates........ SP target 1,635p

Had a few bob on OCDO OCADO. Today they have upped slots for delivery afer about 7 days of a freeze. The fall today looks well over done about 5.6%.

Brokers in general very upbeat about forward prospects.

Latest broker views

Date Broker Recomm. Current Price Price when issued Old price New price

07 Apr 20 Berenberg Buy 1,328.00 1,389.00 1,635.00 -
20 Mar 20 JP Morgan Cazenove Neutral 1,328.00 1,435.00 1,090.00 1,400.00
19 Mar 20 Peel Hunt Buy 1,328.00 1,479.50 1,700.00 -

Latest update....... https://www.investegate.co.uk/ocado-group-plc--ocdo-/rns/trading-statement/202003190700077183G/

Ocado Retail Q1 Trading Statement

Growth in line with guidance; no significant impact of Covid 19 in the quarter

Highlights

? Growth in Retail Revenue of 10.3%, in line with guidance, with average order size up slightly

? Ocado Zoom, our immediacy offering, continues to perform well and we continue to progress plans for a further site

? With customers' concerns over the Coronavirus, since the quarter end, we are seeing higher value baskets with an increase in mix of ambient goods, as well as an increased demand for orders

? While this has placed the business under unprecedented strain, we are taking all measures to ensure that our service remains as close to normal as possible and to meet as much of the demand as we can.

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^OCDO&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Open Short Positions in Novacyt
There are currently no open short positions in Novacyt.

Buyers coming back into the market at the present spread.............

Recent tradesTrades today: 1,512
Trade time Trade price Trade quantity Buy/Sell Bid price Ask price
06 Apr 15:43:57 215.75 468 Buy 210.00 217.00
06 Apr 15:43:29 216.13 5,000 Buy 210.00 217.00
06 Apr 15:42:50 216.13 2,307 Buy 210.00 217.00
06 Apr 15:41:48 215.75 133 Buy 210.00 217.00
06 Apr 15:41:45 216.50 3,765 Buy 210.00 217.00
06 Apr 15:41:42 213.00 162 Sell 210.00 217.00
06 Apr 15:40:15 215.00 2,788 Buy 210.00 217.00
06 Apr 15:40:00 215.00 700 Buy 210.00 217.00
06 Apr 15:39:59 215.00 2,325 Buy 210.00 217.00
06 Apr 15:39:18 215.75 1,000 Buy 210.00 217.00
06 Apr 15:39:03 212.55 1,718 Sell 210.00 217.00
06 Apr 15:38:38 212.12 5,000 Sell 210.00 217.00
06 Apr 15:38:36 215.15 10,000 Buy 210.00 217.00
06 Apr 15:38:16 213.12 239 Sell 210.00 217.00
06 Apr 15:37:57 215.15 173 Buy 210.00 217.00
06 Apr 15:37:21 214.00 1,000 Buy 210.00 217.00
06 Apr 15:37:15 215.15 3,482 Buy 210.00 217.00
06 Apr 15:37:09 214.00 5,000 Buy 210.00 217.00
06 Apr 15:36:40 215.75 179 Buy 210.00 217.00
06 Apr 15:35:32 215.58 1,620 Buy 210.00 217.00
06 Apr 15:33:29 215.75 40 Buy 210.00 217.00
06 Apr 15:32:47 215.00 456 Buy 210.00 217.00
06 Apr 15:32:45 214.00 1,000 Buy 210.00 217.00
06 Apr 15:31:40 214.00 300 Buy 210.00 217.00
06 Apr 15:31:31 215.75 87 Buy 210.00 217.00
06 Apr 15:31:21 215.75 250 Buy 210.00 217.00
06 Apr 15:29:26 216.95 2,030 Buy 210.00 218.00
06 Apr 15:29:25 216.95 501 Buy 210.00 218.00
06 Apr 15:28:20 214.00 476 Buy 210.00 218.00
06 Apr 15:27:36 214.50 5,000 Sell 212.00 218.00
06 Apr 15:25:55 217.88 543 Buy 212.00 218.00
06 Apr 15:25:11 214.45 3,168 Buy 212.00 215.00
06 Apr 15:24:29 214.44 2,312 Buy 212.00 215.00
06 Apr 15:23:08 212.20 118 Sell 212.00 215.00
06 Apr 15:23:06 213.74 581 Buy 212.00 215.00
06 Apr 15:22:49 213.74 850 Buy 212.00 215.00
06 Apr 15:22:36 213.74 231 Buy 212.00 215.00
06 Apr 15:21:58 213.45 1,402 Sell 212.00 215.00
06 Apr 15:21:57 213.45 281 Sell 212.00 215.00
06 Apr 15:21:05 213.45 137 Sell 212.00 215.00
06 Apr 15:20:51 213.45 585 Buy 210.00 215.00
06 Apr 15:18:52 213.00 10 Buy 210.00 215.00
06 Apr 15:18:47 213.00 936 Buy 210.00 215.00
06 Apr 15:18:29 213.00 962 Buy 210.00 215.00
06 Apr 15:18:03 213.00 2,345 Buy 210.00 215.00
06 Apr 15:17:59 213.00 5,000 Buy 210.00 215.00
06 Apr 15:17:50 213.74 171 Buy 208.00 215.00
06 Apr 15:17:04 209.50 196 Buy 208.00 210.00
06 Apr 15:16:46 209.50 5,000 Buy 208.00 210.00
06 Apr 15:16:33 209.50 4,768 Buy 208.00 210.00
Last PagePage

Lifted from advfn.....

Scapa - Factories “essential business” status
108p Epic code: SCPA

(Sharewatch) • I have been watching Scapa (SCPA; 108p) for a re-entry point for some time. First time round on SCSW we did very well, tipping the shares in Nov‘11 at 47p and selling at 355p in Dec.’18.
Back in 2011, Scapa’s mainstay was industrial tape. These are tapes based on silicon, acrylic or other materials and fall into a range of applications where there is a need to attach, identify or protect something. Scapa’s portfolio ranges from masking tape, tape for identification of electrical wiring right through to tape for sticking a Peugeot badge on the grill of a car; tapes are usually sold under the brand of its OEM.
In 2008 the business came unstuck in the credit crunch nastiness. Almost overnight, when houses stopped being built and cars stopped selling, Scapa's distributors began to destock and against the background of a bloated cost base, debts ballooning and a large pension deficit, Scapa could easily have disappeared into the mists of time.
But it survived and under chief executive Heejae Chae, an old Volex-hand, Scapa was radically reshaped. Costs were cut and disposals of non-core parts made and Chae’s cool head approach was to transition the business into the higher margin and higher growth medical sector. The products that Scapa targeted were based on silicon gel eg. disposable adhesive pads for medical devices such as heart monitors that are attached to patients; transdermal patches, which slowly release drugs through the skin; and also advanced woundcare, making sheeting for plasters. Chae’s insight was to target turnkey or one-stop-shop packaged contracts, which landed big multi-year parcels of work. This culminated in three technology transfers of manufacturing assets. The biggest was Systagenix’s site in Yorkshire for £31.4m in 2018. It brought in a team of R&D scientists, a new microbiology lab and a dedicated gamma sterilisation facility.
But the deal pushed a rival’s nose out of joint (ConvaTec) causing it to abandon its own US$30m contract with Scapa. Scapa reacted by cutting its labour outgoings in a bid to mitigate the fallout and Chae reversed his earlier decision to retire in order to put out the fire. Scapa says it did no wrong and has filed for damages of US$83.8m.
On Numis’ forecast eps of 13.2p for the year just ended (Scapa says it has met forecasts) and 15.1p for the year started 1 April, the PE falls to 7.2, which is not demanding for a medtech outsourcer. All Scapa’s sites have been assigned “essential business” status, which means they are up and running. Maybe some sites could be repurposed to make masks. I don’t know when but somewhere up ahead there will be a big buy opportunity.

NYCT

Yep up 16.35% now.

Trades today: 1040

Recent tradesTrades today: 1,037
Trade time Trade price Trade quantity Buy/Sell Bid price Ask price
06 Apr 12:12:47 227.00 218 Buy 220.00 230.00
06 Apr 12:11:48 227.00 4,000 Buy 220.00 230.00
06 Apr 12:11:42 227.00 449 Buy 220.00 230.00
06 Apr 12:10:09 225.00 518 Buy 220.00 225.00
06 Apr 12:09:30 225.00 1,000 Buy 220.00 225.00
06 Apr 12:09:27 225.00 450 Buy 220.00 225.00
06 Apr 12:09:20 222.40 352 Sell 220.00 225.00
06 Apr 12:08:16 224.30 5,000 Buy 220.00 225.00
06 Apr 12:08:11 224.90 67 Buy 220.00 225.00
06 Apr 12:07:57 224.30 222 Buy 220.00 225.00
06 Apr 12:07:52 224.30 450 Buy 220.00 225.00
06 Apr 12:05:39 224.49 1,024 Buy 220.00 225.00
06 Apr 12:05:38 224.49 1,500 Buy 220.00 225.00
06 Apr 12:05:35 224.50 10,000 Buy 220.00 225.00
06 Apr 12:05:16 222.00 1,000 Sell 220.00 225.00
06 Apr 12:04:59 224.50 354 Buy 220.00 225.00
06 Apr 12:04:56 224.50 500 Buy 220.00 225.00
06 Apr 12:04:13 224.00 6,000 Buy 220.00 225.00
06 Apr 12:03:48 224.00 1,339 Buy 220.00 225.00
06 Apr 12:03:03 223.70 447 Buy 220.00 225.00

Breaking out again to next leg up.......

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^NCYT&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

https://uk.advfn.com/p.php?pid=legacyintra&epic=L^NCYT&type=1&size=3&period=a&freq=1&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Volume gradually picking up.

Tipped in this weekends SCSW tip sheet. Ready for making masks ?.

SCPA starting to move up now.

https://uk.advfn.com/p.php?pid=legacyintra&epic=L^SCPA&type=1&size=3&period=a&freq=1&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Healthcare group Novacyt wins French approval for COVID testing product
06-04-2020 07:12

PARIS, April 6 (Reuters) – Novacyt's

COVID-19 testing product has been approved by France's CNR arm of the Institut Pasteur, making it available for immediate distribution in France, the healthcare company said on Monday.

The company added that last week, it had also won approval for its COVID-19 test from Thailand's Ministry of Health.

(Reporting by Sudip Kar-Gupta Editing by David Goodman) ((sudip.kargupta@thomsonreuters.com; +33 1 49 49 53 84;)

Thanks WB, thats a game changer then. The value here is considerably more than investors are presently pricing in, and given the upcoming news we should see the stock explode upwards. Many thanks mick

thanks Wolfiebill how do i find afroWs post please. not doubting you just want to post it tom 3700 twitter followers. Your help appreciated tia mick

This may be a silly question, but does anyone know if this kit test for antigens ???????????????????????????

help much appreciated tia mick

Yesterdays RNS for NCYT......

https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/coronavirus-test-update/202003300700079622H/

Graham Mullis, Chief Executive Officer of Novacyt, commented:

"We continue to report unprecedented demand for our COVID-19 test as the rate of growth in orders increases each week and continues to exceed our expectations. As a result, and despite our best efforts to ensure we ar e fully prepared to meet demand, the rate of sales growth is beginning to be restricted by our ability to scale-up manufacturing as quickly as we would like. This, therefore, remains an immediate priority for the Company and it is our objective to make as many tests available to as many clinicians around the world as quickly as possible. We are very pleased with how our manufacturing partners, BioType and Yourgene, are supporting Novacyt during this time and we continue to evaluate additional capacity enhancing options to address the global demand for our COVID-19 test. Again, I would like to thank all of our employees and suppliers for their ongoing hard work and support during this pandemic."

NYCT.......just part of the link above. Added a few more on the fall this morning. Looks like spivs doing a quick turn on the stock lowering it aided by the MMs with shifts in the spread.

===========================================================================

Novacyt S.A* (NCYT.L): COVID-19 test update Share price: 171p; Market Capitalisation: £115m

Novacyt provided an update regarding its CE-Mark and research use only COVID-19 test. As of 27 March, the Group has sold and received orders for over £17.8m of its COVID-19 tests. (Friday 20 March: £8.7m sold and received orders). The Group received its largest single order to date, £1.4m from a new customer in India. The Middle-East is becoming a key region, with orders of £1.6m received in c.2 weeks. Novacyt is now supplying tests to over 21 UK hospitals. As the coronavirus outbreak increases the demand for effective diagnostics, Novacyt is now selling its test to over 80 countries and last week received emergency use authorisation from the US FDA. Novacyt’s COVID-19 test can be used on multiple laboratory instrument platforms to provide results in under two hours and can be shipped at ambient temperatures. The Company continues to monitor the genomics of the SARS-CoV-2 virus against its COVID-19 test to ensure the accuracy of the test. With growing demand for its test, Novacyt is focused on ramping up manufacturing capacity. The Company, in combination with BioType Diagnostic, a german manufacturing partner, estimates a production rate of c.4m tests per month and has committed to purchasing raw materials to produce c.18m COVID-19 tests. A contract manufacturing services agreement struck last week with AIM-listed Yourgene Health Plc (YGEN.L) should further support capacity whilst the Group progresses discussions with an additional third-party manufacturer.

Tester kits. NYCT....... Novacyt S.A. UK listed.

forgot to mention yesterday took a small punt here in this stock. Seems to be plenty of news flow to come and I noticed the IC top tipster forget his name you know the one shauney worships, flagging up a tester firm yesterday lunch but they never let you see the detail unless you subscribe. Reckon its this one. if not it still looks good going forward.

I intend to drip feed into it if it continues to rise.

****************************/listings/LON/NCYT/

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^NCYT&type=1&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

PLP polypipe........just been reading its last statement.........although scaling down
due to the virus.........

"we have decided to wind down our operations to that which is absolutely necessary to support the Government in its battle with COVID 19 and keep the economy going. These include the following:

· Parts of the Group supporting the National Health Service in very specific roles in increasing capabilities to cope with the inevitable increase in COVID 19 patients. Our Nuaire business is manufacturing ventilation for the Royal Marsden Hospital and is receiving urgent enquiries from many other NHS sites for this as well as other essential projects.

· Our Building Products business has been requested to manufacture special pipe for emergency medical use".